Meet the OBR Editorial Board

Editor's Note: At OBR we have created an editorial board of renown thought leaders in different cancer disease areas. The role of our editorial board is to provide valuable insights through editorial commentary accompanying our daily news. We call it virtual access. By providing our insights into the daily news, you will have access into how these thought leading oncologists interpret the oncology news and events we carry in OBR daily. We hope that our editorial boards's insights will bring great value to the oncology community.

View all Editorial Board Member Commentary

Browse Editors by Section

member-photo

Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center

Comments

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) in Combination With Chemotherapy for Patients With Locally Recurrent Unresectable or Metastatic Triple‑Negative Breast Cancer Whose Tumors Express PD-L1 (CPS ≥10)

quotesThe second immunotherapy approval for triple negative breast cancer came on the heels of the KEYNOTE…quotes

member-photo

Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Wood Johnson Medical School
Rutgers-CINJ Associate Director, Clinical Research
Director Clinical Oncology Research, RWJ-B Health System

Comments

Triple Chemo Combo Improves CRC Outcomes

quotesS1406 was a randomized phase II study of 100 patients with RAS wt, BRAF V600E mutated CRC in 2nd-3rd…quotes

member-photo

Ted Okon

Executive Director
Community Oncology Alliance

Comments

New Study Finds COVID-19 Substantially Reduced Cancer Screenings, Diagnosis, and Treatments in 2020

quotesThis is a very important but scary study we conducted. Cancer screenings are still down and we have …quotes

member-photo

William McGivney, PhD

National Health Policy Expert

Comments

Community Oncology Alliance (COA) Payment Reform Brief Details 35 Oncology Payment Models Underway or Planned Across Country

quotesCOA leaders clearly are among the elite as experts nationally in the understanding and design of pay…quotes

member-photo

Tomasz M. Beer, MD, FACP

Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine
Grover C. Bagby Chair of Prostate Cancer Research
OHSU Knight Cancer Institute Deputy Director, OHSU Knight Cancer Institute, School of Medicine
Chief Medical Officer, CEDAR, OHSU Knight Cancer Institute, School of Medicine

Comments

UCSF, UCLA Gain FDA Approval for Prostate Cancer Imaging Technique

quotesPSMA PET-CT imaging is now clinically available at 2 institutions in the US. This is an important s…quotes

member-photo

Tomasz M. Beer, MD, FACP

Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine
Grover C. Bagby Chair of Prostate Cancer Research
OHSU Knight Cancer Institute Deputy Director, OHSU Knight Cancer Institute, School of Medicine
Chief Medical Officer, CEDAR, OHSU Knight Cancer Institute, School of Medicine

Comments

UCSF, UCLA Gain FDA Approval for Prostate Cancer Imaging Technique

quotesPSMA PET-CT imaging is now clinically available at 2 institutions in the US. This is an important s…quotes

member-photo

Dean Gesme, MD

FACP FACPE FASCO
President, Minnesota Oncology

Comments

Op-Ed: How Trump’s New Drug Pricing Scheme Hurts Cancer Patients

quotesThe Most Favored Nation (MFN) Interim Final Rule from CMS concerning Medicare infused drug pricing i…quotes

member-photo

Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center

Comments

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) in Combination With Chemotherapy for Patients With Locally Recurrent Unresectable or Metastatic Triple‑Negative Breast Cancer Whose Tumors Express PD-L1 (CPS ≥10)

quotesThe second immunotherapy approval for triple negative breast cancer came on the heels of the KEYNOTE…quotes

member-photo

H. Jack West, MD

Associate Clinical Professor, Medical Oncology
Executive Director, Employer Services
City of Hope Comprehensive Cancer Center
Duarte, CA

Comments

Targeted Combo Fails in EGFR-Mutant NSCLC

quotesAs I stated in the Editor's Note that accompanied this article, there is nothing about the research …quotes

member-photo

Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Wood Johnson Medical School
Rutgers-CINJ Associate Director, Clinical Research
Director Clinical Oncology Research, RWJ-B Health System

Comments

Triple Chemo Combo Improves CRC Outcomes

quotesS1406 was a randomized phase II study of 100 patients with RAS wt, BRAF V600E mutated CRC in 2nd-3rd…quotes

member-photo

Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics
Professor and Chair, Department of Radiation Oncology
Interim Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center

Comments

New Scan Finds Prostate Cancer Cells Hiding in the Body

quotesCan't emphasize how important the PSMA PET scan will be in the routine management of prostate cancer…quotes

member-photo

Robert A. Figlin, MD., FACP

Steven Spielberg Family Chair in Hematology Oncology
Professor of Medicine and Biomedical Sciences
Deputy Director, Cedars-Sinai Cancer
Deputy Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center

Comments

CT Scans Can Reduce Lung Cancer Deaths, Study Finds

quotesThis long awaited trial performed by the National Cancer Institute demonstrates the benefits of low …quotes

member-photo

Stephen M. Schleicher, M.D., MBA

Community Oncology,
Medical Oncologist,
OneOncology

Comments

Divergent Findings With Paclitaxel and Nab-Paclitaxel in TNBC

quotesThe finding that atezolizumab is beneficial only with Abraxane and NOT paclitaxel not only has impor…quotes

member-photo

Ted Okon

Executive Director
Community Oncology Alliance

Comments

New Study Finds COVID-19 Substantially Reduced Cancer Screenings, Diagnosis, and Treatments in 2020

quotesThis is a very important but scary study we conducted. Cancer screenings are still down and we have …quotes

member-photo

Thomas Marsland, MD

Vice President
Integrated Community Oncology Network
Former Community Representative
ASCO Board of Directors

Comments

CVS Health Collaborates With Cancer Treatment Centers of America to Provide In-Home Chemotherapy

quotesHmmm, another nail in the coffin of community based cancer care???? I am never happy to see "corpora…quotes

member-photo

William McGivney, PhD

National Health Policy Expert

Comments

Community Oncology Alliance (COA) Payment Reform Brief Details 35 Oncology Payment Models Underway or Planned Across Country

quotesCOA leaders clearly are among the elite as experts nationally in the understanding and design of pay…quotes

member-photo

H. Jack West, MD

Associate Clinical Professor, Medical Oncology
Executive Director, Employer Services
City of Hope Comprehensive Cancer Center
Duarte, CA

Comments

Targeted Combo Fails in EGFR-Mutant NSCLC

quotesAs I stated in the Editor's Note that accompanied this article, there is nothing about the research …quotes

member-photo

Robert A. Figlin, MD., FACP

Steven Spielberg Family Chair in Hematology Oncology
Professor of Medicine and Biomedical Sciences
Deputy Director, Cedars-Sinai Cancer
Deputy Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center

Comments

CT Scans Can Reduce Lung Cancer Deaths, Study Finds

quotesThis long awaited trial performed by the National Cancer Institute demonstrates the benefits of low …quotes

member-photo

Dean Gesme, MD

FACP FACPE FASCO
President, Minnesota Oncology

Comments

Op-Ed: How Trump’s New Drug Pricing Scheme Hurts Cancer Patients

quotesThe Most Favored Nation (MFN) Interim Final Rule from CMS concerning Medicare infused drug pricing i…quotes

member-photo

Thomas Marsland, MD

Vice President
Integrated Community Oncology Network
Former Community Representative
ASCO Board of Directors

Comments

CVS Health Collaborates With Cancer Treatment Centers of America to Provide In-Home Chemotherapy

quotesHmmm, another nail in the coffin of community based cancer care???? I am never happy to see "corpora…quotes

member-photo

Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics
Professor and Chair, Department of Radiation Oncology
Interim Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center

Comments

New Scan Finds Prostate Cancer Cells Hiding in the Body

quotesCan't emphasize how important the PSMA PET scan will be in the routine management of prostate cancer…quotes